Below is a list of forthcoming submissions that have recently been added to the SMC's programme.

• Atazanavir sulphate with cobicistat (Evotaz)
• Ceritinib (Zykadia)
• Dalbavancin (Xydalba)
• Edoxaban tosylate (Lixiana) (VTE)
• Edoxaban tosylate (Lixiana) NVAF
• Efavirenz (Sustiva)
• Ivermectin (Soolantra)
• Lenalidamide (Revlimid)
• Levodopa with carbidopa (Duodopa)
• Tiotropium bromide monohydate with olodaterol hydrochloride (Spiolto Respimat)
• Tolvaptan (Jinarc)

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2ICSSBDQBC